The Semax+Selank Blend (XS-20) is a synthetic research peptide blend combining equal amounts of Semax and Selank, two neuropeptides of interest in vitro receptor binding and signaling studies, supplied in a single lyophilized vial for in vitro and laboratory research purposes.
This material is supplied by Rainier Compounds exclusively as a laboratory research reagent for use by qualified personnel in controlled, non-clinical environments. It is not approved by the FDA or any regulatory agency for diagnostic, therapeutic, clinical, or veterinary use.
Chemical Details
Blend Class: Synthetic dual-neuropeptide research blend
Semax Component: ACTH-derived heptapeptide, CAS 80714-61-0
Selank Component: tuftsin analogue heptapeptide, CAS 129954-34-3
Combined Specification: 20mg per vial (10mg Semax + 10mg Selank)
Form: Lyophilized powder in sealed glass vial
Purity: ≥98% by HPLC
Storage
Store at -20°C, desiccated, and protected from light. Avoid repeated freeze-thaw cycles. Reconstitute in sterile aqueous solution for in vitro applications.
Important Notice
This product is supplied strictly for laboratory research applications by qualified personnel in controlled, non-clinical environments. It is not intended for human consumption, clinical use, diagnostic use, therapeutic use, or veterinary use. By completing a purchase, the buyer confirms they are a qualified researcher and agrees to use this material exclusively within those terms. Rainier Compounds bears no liability for any use outside of legitimate laboratory research.
